New ETEC vaccine technology targeting enterotoxigenic Escherichia coli has been licensed to Valneva after decades of research ...
Respiratory viruses continue to pose significant public health challenges globally, including influenza viruses, coronaviruses etc. While existing vaccines have made substantial progress in protecting ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in ...
Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been ...
An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...
NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...
Jonathan Kurtis ’89 PhD’95 MD’96, professor of pathology and laboratory medicine, did not first develop an interest in malaria behind a lab bench or as a training physician in a clinical setting.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results